1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Glucose Intolerance Global Clinical Trials Review, H1, 2014

Glucose Intolerance Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, “Glucose Intolerance Global Clinical Trials Review, H1, 2014" provides data on the Glucose Intolerance clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Glucose Intolerance. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Glucose Intolerance. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Glucose Intolerance Global Clinical Trials Review, H1, 2014
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Glucose Intolerance 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Glucose Intolerance to Metabolic Disorders Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Glucose Intolerance to Metabolic Disorders Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Glucose Intolerance 25
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Glucose Intolerance Therapeutics Clinical Trials 29
Prominent Drugs 31
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
Merck and Co., Inc. 32
Clinical Trial Overview of Merck and Co., Inc. 32
Genfit SA 33
Clinical Trial Overview of Genfit SA 33
Novartis AG 34
Clinical Trial Overview of Novartis AG 34
N-Gene Research Laboratories, Inc. 35
Clinical Trial Overview of N-Gene Research Laboratories, Inc. 35
Laboratoires Stella SA 36
Clinical Trial Overview of Laboratoires Stella SA 36
Johnson and Johnson 37
Clinical Trial Overview of Johnson and Johnson 37
Clinical Trial Overview of Top Institutes / Government 38
Yale University 38
Clinical Trial Overview of Yale University 38
The National Institute of Diabetes and Digestive and Kidney Diseases 39
Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases 39
Hadassah Medical Organization 40
Clinical Trial Overview of Hadassah Medical Organization 40
Maastricht University Medical Center 41
Clinical Trial Overview of Maastricht University Medical Center 41
University of Oslo 42
Clinical Trial Overview of University of Oslo 42
Eunice Kennedy Shriver National Institute of Child Health and Human Development 43
Clinical Trial Overview of Eunice Kennedy Shriver National Institute of Child Health and Human Development 43
Universite de Sherbrooke 44
Clinical Trial Overview of Universite de Sherbrooke 44
Academic Medical Center 45
Clinical Trial Overview of Academic Medical Center 45
University of Tasmania 46
Clinical Trial Overview of University of Tasmania 46
Chinese University of Hong Kong 47
Clinical Trial Overview of Chinese University of Hong Kong 47
Five Key Clinical Profiles 48
Appendix 75
Abbreviations 75
Definitions 75
Research Methodology 76
Secondary Research 76
About GlobalData 77
Contact Us 77
Disclaimer 77
Source 78

List of Tables
Glucose Intolerance Therapeutics, Global, Clinical Trials by Region, 2014* 7
Glucose Intolerance Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Glucose Intolerance Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Glucose Intolerance Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Glucose Intolerance Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Glucose Intolerance Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Glucose Intolerance Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Glucose Intolerance Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
Proportion of Glucose Intolerance to Metabolic Disorders Clinical Trials, G7 Countries (%), 2014* 15
Glucose Intolerance Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Glucose Intolerance Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Glucose Intolerance to Metabolic Disorders Clinical Trials, E7 Countries (%), 2014* 18
Glucose Intolerance Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Glucose Intolerance Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Glucose Intolerance Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Glucose Intolerance Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Glucose Intolerance Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Glucose Intolerance Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Glucose Intolerance Therapeutics, Global, Terminated Clinical Trials, 2014* 25
Glucose Intolerance Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 26
Glucose Intolerance Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 27
Glucose Intolerance Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 28
Glucose Intolerance Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30
Glucose Intolerance Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 31
Glucose Intolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck and Co., Inc., 2014* 32
Glucose Intolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Genfit SA, 2014* 33
Glucose Intolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 34
Glucose Intolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by N-Gene Research Laboratories, Inc., 2014* 35
Glucose Intolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Laboratoires Stella SA, 2014* 36
Glucose Intolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson and Johnson, 2014* 37
Glucose Intolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Yale University, 2014* 38
Glucose Intolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Diabetes and Digestive and Kidney Diseases, 2014* 39
Glucose Intolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Hadassah Medical Organization, 2014* 40
Glucose Intolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Maastricht University Medical Center, 2014* 41
Glucose Intolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Oslo, 2014* 42
Glucose Intolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Eunice Kennedy Shriver National Institute of Child Health and Human Development, 2014* 43
Glucose Intolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Universite de Sherbrooke, 2014* 44
Glucose Intolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic Medical Center, 2014* 45
Glucose Intolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Tasmania, 2014* 46
Glucose Intolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Chinese University of Hong Kong, 2014* 47

List of Figures
Glucose Intolerance Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Glucose Intolerance Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Glucose Intolerance Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Glucose Intolerance Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Glucose Intolerance Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Glucose Intolerance Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Glucose Intolerance Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13
Glucose Intolerance Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014* 14
Proportion of Glucose Intolerance to Metabolic Disorders Clinical Trials, G7 Countries (%), 2014* 15
Glucose Intolerance Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Glucose Intolerance Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Glucose Intolerance to Metabolic Disorders Clinical Trials, E7 Countries (%), 2014* 18
Glucose Intolerance Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Glucose Intolerance Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Glucose Intolerance Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Glucose Intolerance Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Glucose Intolerance Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Glucose Intolerance Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Glucose Intolerance Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 26
Glucose Intolerance Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 27
Glucose Intolerance Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 28
Glucose Intolerance Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 29
Glucose Intolerance Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 31
GlobalData Methodology 76

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.